Search company, investor...

Predict your next investment

Venture Capital
npv.vc

Investments

109

Portfolio Exits

12

Partners & Customers

1

Service Providers

1

About Northpond Ventures

Northpond Ventures is a science-driven venture capital firm headquartered in Bethesda, MD.

Headquarters Location

7500 Old Georgetown Road Suite 850

Bethesda, Maryland, 20814,

United States

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest Northpond Ventures News

Aro Biotherapeutics Secures $41.5M Series B Financing

Nov 28, 2023

PHILADELPHIA--(BUSINESS WIRE)--Aro Biotherapeutics, a clinical stage biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced it has secured $41.5M in a Series B funding round. The round was led by Cowen Healthcare Investments, with participation from existing investors from Aro’s Series A financing round in 2020, including Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Northpond Ventures, Healthcap and BVF Partners, L.P. In conjunction with

Northpond Ventures Investments

109 Investments

Northpond Ventures has made 109 investments. Their latest investment was in Octave Bioscience as part of their Series B - IV on November 11, 2023.

CBI Logo

Northpond Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/24/2023

Series B - IV

Octave Bioscience

$7M

No

1

11/3/2023

Series B - II

Scitara

$15M

No

1

8/25/2023

Seed VC - II

Gesund.ai

Yes

1

8/3/2023

Series B - II

Subscribe to see more

$99M

Subscribe to see more

10

7/26/2023

Series B - III

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/24/2023

11/3/2023

8/25/2023

8/3/2023

7/26/2023

Round

Series B - IV

Series B - II

Seed VC - II

Series B - II

Series B - III

Company

Octave Bioscience

Scitara

Gesund.ai

Subscribe to see more

Subscribe to see more

Amount

$7M

$15M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

1

10

10

Northpond Ventures Portfolio Exits

12 Portfolio Exits

Northpond Ventures has 12 portfolio exits. Their latest portfolio exit was Isolere Bio on February 21, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/21/2023

Acquired

$99M

6

1/30/2023

Acquired

$99M

1

5/4/2022

Acquired

$99M

1

1/7/2022

IPO

Subscribe to see more

$99M

Subscribe to see more

10

12/23/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/21/2023

1/30/2023

5/4/2022

1/7/2022

12/23/2021

Exit

Acquired

Acquired

Acquired

IPO

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

6

1

1

10

10

Northpond Ventures Acquisitions

1 Acquisition

Northpond Ventures acquired 1 company. Their latest acquisition was Saama Technologies on October 20, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/20/2021

Debt

$99M

$79.25M

Acq - Fin

14

Date

10/20/2021

Investment Stage

Debt

Companies

Valuation

$99M

Total Funding

$79.25M

Note

Acq - Fin

Sources

14

Northpond Ventures Partners & Customers

1 Partners and customers

Northpond Ventures has 1 strategic partners and customers. Northpond Ventures recently partnered with Massachusetts Institute of Technology on June 6, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

6/15/2022

Partner

United States

MIT-Northpond Program Created to Advance Innovation in Engineering and Life Science. Cambridge, MA | June 15, 2022 — MIT School of Engineering and Northpond Ventures today announced the launch of the MIT-Northpond Program – Advancing Life Science & Engineering Innovation.

`` Through this program , we can provide transformational entrepreneurial and business opportunities to MIT 's incredible engineering and science talent , '' said Sharon Kedar , co-founder and partner of Northpond Ventures .

1

Date

6/15/2022

Type

Partner

Business Partner

Country

United States

News Snippet

MIT-Northpond Program Created to Advance Innovation in Engineering and Life Science. Cambridge, MA | June 15, 2022 — MIT School of Engineering and Northpond Ventures today announced the launch of the MIT-Northpond Program – Advancing Life Science & Engineering Innovation.

`` Through this program , we can provide transformational entrepreneurial and business opportunities to MIT 's incredible engineering and science talent , '' said Sharon Kedar , co-founder and partner of Northpond Ventures .

Sources

1

Northpond Ventures Service Providers

1 Service Provider

Northpond Ventures has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

General Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

Northpond Ventures Team

6 Team Members

Northpond Ventures has 6 team members, including , .

Name

Work History

Title

Status

ShaRon Kedar

Sands Capital, and McKinsey & Company

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

ShaRon Kedar

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Sands Capital, and McKinsey & Company

Title

Founder

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.